216
Participants
Start Date
July 13, 2021
Primary Completion Date
February 13, 2026
Study Completion Date
February 10, 2027
JNJ-78278343
JNJ-78278343 will be administered.
ACTIVE_NOT_RECRUITING
Columbia University Medical Center Herbert Irving Pavilion, New York
ACTIVE_NOT_RECRUITING
Memorial Sloan Kettering Cancer Center, New York
COMPLETED
APHM Hopital Timone, Marseille
RECRUITING
Hosp Univ Fund Jimenez Diaz, Madrid
COMPLETED
Hosp Univ Hm Sanchinarro, Madrid
RECRUITING
Hosp Virgen de La Victoria, Málaga
RECRUITING
Centre Leon Berard, Lyon
RECRUITING
Institut Gustave Roussy, Villejuif
ACTIVE_NOT_RECRUITING
Peking University Third Hospital, Beijing
ACTIVE_NOT_RECRUITING
First Affiliated Hospital Of Wenzhou Medical College, Wenzhou
ACTIVE_NOT_RECRUITING
Chongqing University Cancer Hospital, Chongqing
ACTIVE_NOT_RECRUITING
Sun Yat Sen University Cancer Center, Guangzhou
ACTIVE_NOT_RECRUITING
University of Washington, Seattle
ACTIVE_NOT_RECRUITING
National Cancer Center Hospital East, Kashiwa
ACTIVE_NOT_RECRUITING
Yokohama City University Medical Center, Yokohama
COMPLETED
Antoni van Leeuwenhoek, Amsterdam
COMPLETED
Erasmus MC, Rotterdam
Janssen Research & Development, LLC
INDUSTRY